BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 28791994)

  • 1. [Expression of epidermal growth factor receptor in patients with insulin resistance and seborrheic keratomas].
    Smolyannikova VA; Alexandrova AK
    Arkh Patol; 2017; 79(4):18-21. PubMed ID: 28791994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low incidence of oncogenic EGFR, HRAS, and KRAS mutations in seborrheic keratosis.
    Georgieva IA; Mauerer A; Groesser L; Herschberger E; Aslanidis C; Dietmaier W; Landthaler M; Hafner C
    Am J Dermatopathol; 2014 Aug; 36(8):635-42. PubMed ID: 23739246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
    Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G
    Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a novel therapeutic approach using a retinoic acid-loaded microneedle patch for seborrheic keratosis treatment and safety study in humans.
    Hiraishi Y; Hirobe S; Iioka H; Quan YS; Kamiyama F; Asada H; Okada N; Nakagawa S
    J Control Release; 2013 Oct; 171(2):93-103. PubMed ID: 23791975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impaired expression of cell-cycle regulatory proteins in seborrheic keratosis].
    Smolyannikova VA; Aleksandrova AK
    Arkh Patol; 2020; 82(2):30-34. PubMed ID: 32307436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of insulin-like growth factor 1 receptor (IGF-1R) predicts poor responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer patients harboring activating EGFR mutations.
    Yeo CD; Park KH; Park CK; Lee SH; Kim SJ; Yoon HK; Lee YS; Lee EJ; Lee KY; Kim TJ
    Lung Cancer; 2015 Mar; 87(3):311-7. PubMed ID: 25617986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A ligand-based and enediyne-energized bispecific fusion protein targeting epidermal growth factor receptor and insulin-like growth factor-1 receptor shows potent antitumor efficacy against esophageal cancer.
    Cao HY; Guo XF; Zhu XF; Li SS; Zhen YS
    Oncol Rep; 2017 Jun; 37(6):3329-3340. PubMed ID: 28498434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of alterations in the brain signaling systems regulated by insulin, IGF-1 and leptin in the transition of impaired glucose tolerance to overt type 2 diabetes mellitus].
    Shpakov AO
    Tsitologiia; 2014; 56(11):789-99. PubMed ID: 25707205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insulin sensitivity and beta cell function in different glucose tolerance status].
    Gómez-García A; Magaña-Garns P; Ruiz-García J; Alvarez-Aguilar C
    Invest Clin; 2006 Jun; 47(2):155-66. PubMed ID: 16886777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paracrine cytokine mechanisms underlying the hyperpigmentation of seborrheic keratosis in covered skin areas.
    Takenaka Y; Hoshino Y; Nakajima H; Hayashi N; Kawashima M; Imokawa G
    J Dermatol; 2013 Jul; 40(7):533-42. PubMed ID: 23662587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic basis of seborrheic keratosis and epidermal nevi].
    Hafner C; Hafner H; Groesser L
    Pathologe; 2014 Sep; 35(5):413-23. PubMed ID: 25187080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The relation of insulin resistance with the complications of diabetes mellitus type 2 and metabolic parameters].
    Lomtadze I; Virsaladze D; Koplatadze M; Mikashavidze T
    Georgian Med News; 2008 Jan; (154):26-9. PubMed ID: 18323588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profiles of cortisol-inactivating enzyme, 11β-hydroxysteroid dehydrogenase-2, in human epidermal tumors and its role in keratinocyte proliferation.
    Terao M; Itoi S; Murota H; Katayama I
    Exp Dermatol; 2013 Feb; 22(2):98-101. PubMed ID: 23362866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR genomic gain and aberrant pathway signaling in pancreatic cancer patients.
    Tzeng CW; Frolov A; Frolova N; Jhala NC; Howard JH; Vickers SM; Buchsbaum DJ; Heslin MJ; Arnoletti JP
    J Surg Res; 2007 Nov; 143(1):20-6. PubMed ID: 17950068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serine Protease Inhibitor Kazal Type 1 (SPINK1) Promotes Proliferation of Colorectal Cancer Through the Epidermal Growth Factor as a Prognostic Marker.
    Chen YT; Tsao SC; Yuan SS; Tsai HP; Chai CY
    Pathol Oncol Res; 2015 Sep; 21(4):1201-8. PubMed ID: 26037168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic evaluation of the epidermal growth factor receptor inhibitor OSI-774 in human epidermis of cancer patients.
    Malik SN; Siu LL; Rowinsky EK; deGraffenried L; Hammond LA; Rizzo J; Bacus S; Brattain MG; Kreisberg JI; Hidalgo M
    Clin Cancer Res; 2003 Jul; 9(7):2478-86. PubMed ID: 12855621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/AKT signaling pathway: rational basis for cotargeting insulin-like growth factor-1 receptor and epidermal growth factor receptor in hepatocellular carcinoma.
    Desbois-Mouthon C; Baron A; Blivet-Van Eggelpoël MJ; Fartoux L; Venot C; Bladt F; Housset C; Rosmorduc O
    Clin Cancer Res; 2009 Sep; 15(17):5445-56. PubMed ID: 19706799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
    Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
    Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 expression is dependent upon epidermal growth factor receptor expression or activation in androgen independent prostate cancer.
    Jia RP; Xu LW; Su Q; Zhao JH; Li WC; Wang F; Xu Z
    Asian J Androl; 2008 Sep; 10(5):758-64. PubMed ID: 18645679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autocrine expression of the epidermal growth factor receptor ligand heparin-binding EGF-like growth factor in cervical cancer.
    Schrevel M; Osse EM; Prins FA; Trimbos JBMZ; Fleuren GJ; Gorter A; Jordanova ES
    Int J Oncol; 2017 Jun; 50(6):1947-1954. PubMed ID: 28498437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.